Announce Date | 04/23/2025 |
EPS Normalized Actual | $3.66 (Beat by $0.16) |
EPS GAAP Actual | $3.66 (Beat by $0.16) |
Revenue Actual | $12.223B |
Revenue Surprise | Beat by $12223M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 21.24 | 12.79 | 20.92322 | 21.7617 | 4 |
Dec 2028 | 20.945 | 12.97 | 20.67994 | 21.26404 | 6 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.69 | 3.69 | 12.223B | 100% | 12223M |
FQ4 2024 (Dec 2024) | 4.2 | 4.2 | 13.338B | 20.75% | 13338M |
FQ3 2024 (Sep 2024) | 3.39 | 3.39 | 0B | -INF% | 0M |
FQ2 2024 (Jun 2024) | 3.3 | 3.3 | 11.976B | 17.49% | 11976M |
FQ1 2024 (Mar 2024) | 2.92 | 2.92 | 0B | NAN% | 0M |
FQ4 2023 (Oct 2023) | 3.07 | 3.07 | 10.571B | 5.64% | 10571M |
FQ3 2023 (Jul 2023) | 3.76 | 3.76 | 10.152B | 9.49% | 10152M |
FQ2 2023 (Apr 2023) | 2.66 | 2.66 | 9.881B | 100% | 9881M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.04069 | -- | 4.81245 | 5.25638 | 8 |
FQ3 2027 (Sep 2027) | 4.34506 | -- | 4.07902 | 4.57823 | 4 |
FQ2 2027 (Jun 2027) | 4.1501 | -- | 3.896 | 4.37281 | 4 |
FQ1 2027 (Mar 2027) | 3.77372 | -- | 3.55683 | 3.97688 | 4 |
FQ4 2026 (Oct 2026) | 4.41105 | -- | 4.08766 | 4.59504 | 6 |
FQ3 2026 (Jul 2026) | 4.04902 | -- | 3.75217 | 4.21791 | 11 |
FQ2 2026 (Jun 2026) | 4.19948 | -- | 3.92812 | 4.42873 | 2 |
FQ1 2026 (Mar 2026) | 3.76396 | 1.96 | 3.52074 | 3.96944 | 3 |
FQ4 2025 (Dec 2025) | 4.57355 | 8.17 | 4.36774 | 4.77186 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 14.71B | -- | 14.2B | 15.2B | 9 |
FQ3 2027 (Sep 2027) | 13.3B | -- | 12.67B | 13.85B | 5 |
FQ2 2027 (Jun 2027) | 13.04B | -- | 12.43B | 13.58B | 5 |
FQ1 2027 (Mar 2027) | 12.24B | -- | 11.7B | 12.75B | 5 |
FQ4 2026 (Oct 2026) | 12.67B | -- | 11.95B | 13.07B | 10 |
FQ3 2026 (Jul 2026) | 12.11B | -- | 11.43B | 12.5B | 10 |
FQ2 2026 (Jun 2026) | 12.76B | -- | 12.13B | 13.3B | 3 |
FQ1 2026 (Mar 2026) | 11.89B | -2.78 | 11.3B | 12.39B | 4 |
FQ4 2025 (Dec 2025) | 13.17B | -1.26 | 12.72B | 13.61B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
6
Revenue # of Misses
0
Revenue # of in-lines
2
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.69 | 3.69 | 100% | |
FQ4 2024 (Dec 2024) | 4.2 | 4.2 | 100% | |
FQ3 2024 (Sep 2024) | 3.39 | 3.39 | 100% | |
FQ2 2024 (Jun 2024) | 3.3 | 3.3 | 100% | |
FQ1 2024 (Mar 2024) | 2.92 | 2.92 | 100% | |
FQ4 2023 (Oct 2023) | 3.07 | 3.07 | 100% | |
FQ3 2023 (Jul 2023) | 3.76 | 3.76 | 100% | |
FQ2 2023 (Apr 2023) | 2.66 | 2.66 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $12.22B | $12223M | 100% |
FQ4 2024 (Dec 2024) | $0B | $13.34B | $13338M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0B | $0M | NAN% |
FQ2 2024 (Jun 2024) | $0B | $11.98B | $11976M | 100% |
FQ1 2024 (Mar 2024) | $0B | $0B | $0M | NAN% |
FQ4 2023 (Oct 2023) | $0B | $10.57B | $10571M | 100% |
FQ3 2023 (Jul 2023) | $0B | $10.15B | $10152M | 100% |
FQ2 2023 (Apr 2023) | $0B | $9.88B | $9881M | 100% |